News
Company Drug Indication Stage; Mitsubishi Tanabe Pharma: MT-5562: Systemic sclerosis: Preclinical: Bridge Biotherapeutics: BBT-877: IPF: Phase 2: Blade Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback